Discover and read the best of Twitter Threads about #bavenovii
Most recents (4)
1/🧵
Part 1⃣ of Session 3⃣ of #BavenoVII
Preventing (first) decompensation
🪑 Chaired by Profs. @jaumebosch9 and @crisripol
🦸 Panelists: R. Bañares, @Calvar1Vincenza, A. Dell’Era, @RodriguesSu24, @dtrip2015 and C. Villanueva 📸
📜 Follow this thread for major statements 👇
Part 1⃣ of Session 3⃣ of #BavenoVII
Preventing (first) decompensation
🪑 Chaired by Profs. @jaumebosch9 and @crisripol
🦸 Panelists: R. Bañares, @Calvar1Vincenza, A. Dell’Era, @RodriguesSu24, @dtrip2015 and C. Villanueva 📸
📜 Follow this thread for major statements 👇
2/5
Definition of decompensation
▪️The panel performed a systematic review for definition of 1⃣ decompensation
▪️Previous landmark study
🔗 pubmed.ncbi.nlm.nih.gov/16298014/
▪️Slides and statements 📜
Definition of decompensation
▪️The panel performed a systematic review for definition of 1⃣ decompensation
▪️Previous landmark study
🔗 pubmed.ncbi.nlm.nih.gov/16298014/
▪️Slides and statements 📜
3/5
🦠 Role of infections in 1⃣ decompensation
▪️Relevant articles
🔗pubmed.ncbi.nlm.nih.gov/33905794/
🔗pubmed.ncbi.nlm.nih.gov/33641234/
▪️Statements📜
🦠 Role of infections in 1⃣ decompensation
▪️Relevant articles
🔗pubmed.ncbi.nlm.nih.gov/33905794/
🔗pubmed.ncbi.nlm.nih.gov/33641234/
▪️Statements📜
1/🧵
Part 3⃣ of Session 2⃣ of #BavenoVII
Impact of non-etiological therapies
🪑 Chaired by Profs. A. Albillos and @JonelTrebicka
🦸 Panelists: @JasmohanBajaj, @JSGracia, @AleksanderKrag
📜 Major statements await for #LiverTwitter 👇
Part 3⃣ of Session 2⃣ of #BavenoVII
Impact of non-etiological therapies
🪑 Chaired by Profs. A. Albillos and @JonelTrebicka
🦸 Panelists: @JasmohanBajaj, @JSGracia, @AleksanderKrag
📜 Major statements await for #LiverTwitter 👇
2/4
Role of statins and aspirin in patients with CLD
📚 Relevant related-articles
▪️Statins
🔗cghjournal.org/action/showPdf…
▪️Aspirin
🔗nejm.org/doi/pdf/10.105…
🔗aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.10…
🔗jamanetwork.com/journals/jamao…
📜 Slides and statements 👇
Role of statins and aspirin in patients with CLD
📚 Relevant related-articles
▪️Statins
🔗cghjournal.org/action/showPdf…
▪️Aspirin
🔗nejm.org/doi/pdf/10.105…
🔗aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.10…
🔗jamanetwork.com/journals/jamao…
📜 Slides and statements 👇
3/4
Role of anticoagulation in patients with CLD
📚 Previous landmark study
▪️pubmed.ncbi.nlm.nih.gov/22819864/
📜 Slide and statements 👇
Role of anticoagulation in patients with CLD
📚 Previous landmark study
▪️pubmed.ncbi.nlm.nih.gov/22819864/
📜 Slide and statements 👇
1/🧵
Part 2⃣ of Session 2⃣ of #BavenoVII
Impact of etiological therapies
🪑 Chaired by Profs. @MattiasMandorf1 and E. Tsochatzis
🦸 Panelists: @FrancqueSven, J. Jia, @SaSi_Lens and H. Yoshiji
📜 Once again, major statements for #Livertwitter have been announced‼️
Part 2⃣ of Session 2⃣ of #BavenoVII
Impact of etiological therapies
🪑 Chaired by Profs. @MattiasMandorf1 and E. Tsochatzis
🦸 Panelists: @FrancqueSven, J. Jia, @SaSi_Lens and H. Yoshiji
📜 Once again, major statements for #Livertwitter have been announced‼️
2/5
🦸 The panel performed an individual patient data-based meta-analysis of the #BavenoVII cooperation, repeating NIT (LSM & PLT) post-treatment to assess the probability of CSPH in a cACLD patient after SVR (📸 1 and 2)
📜 Relevant statements followed 👇
🦸 The panel performed an individual patient data-based meta-analysis of the #BavenoVII cooperation, repeating NIT (LSM & PLT) post-treatment to assess the probability of CSPH in a cACLD patient after SVR (📸 1 and 2)
📜 Relevant statements followed 👇
3/5
🏋️ Let´s test now #LiverTwitter
What is the probability of CSPH in a cACLD patient who has a platelet count of 100 and a TE of 20 kPa after SVR ❓
🏋️ Let´s test now #LiverTwitter
What is the probability of CSPH in a cACLD patient who has a platelet count of 100 and a TE of 20 kPa after SVR ❓
1/🧵
Part 1⃣ Session 1⃣ of #BavenoVII
HVPG as a gold standard
🪑 Chaired by Profs. @jcgarciapagan and H. Ferral
🦸 Panelists: R. Gaba, F. Schepis
📜 Major statements and relevant articles for #Livertwitter 👇
Part 1⃣ Session 1⃣ of #BavenoVII
HVPG as a gold standard
🪑 Chaired by Profs. @jcgarciapagan and H. Ferral
🦸 Panelists: R. Gaba, F. Schepis
📜 Major statements and relevant articles for #Livertwitter 👇
2/4
Quality Metrics in HVPG and PPG
▪️Balloon vs straight catheter for HVPG
onlinelibrary.wiley.com/doi/epdf/10.11…
▪️Hepatic-atrial PG
aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.10…
▪️Accuracy of HVPG technique
aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.10…
▪️Impact of Intrahepatic Venovenous Shunt on HVPG
pubmed.ncbi.nlm.nih.gov/33261743/
Quality Metrics in HVPG and PPG
▪️Balloon vs straight catheter for HVPG
onlinelibrary.wiley.com/doi/epdf/10.11…
▪️Hepatic-atrial PG
aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.10…
▪️Accuracy of HVPG technique
aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.10…
▪️Impact of Intrahepatic Venovenous Shunt on HVPG
pubmed.ncbi.nlm.nih.gov/33261743/
3/4
Usefulness of HVPG in different settings
▪️Agreement of wedged hepatic and portal pressure in NAFLD
pubmed.ncbi.nlm.nih.gov/33068638/
▪️CSPH:
pubmed.ncbi.nlm.nih.gov/17681169/
▪️Acute hemodynamic response:
pubmed.ncbi.nlm.nih.gov/19344721/
▪️Test-retest reliability:
pubmed.ncbi.nlm.nih.gov/34181770/
Usefulness of HVPG in different settings
▪️Agreement of wedged hepatic and portal pressure in NAFLD
pubmed.ncbi.nlm.nih.gov/33068638/
▪️CSPH:
pubmed.ncbi.nlm.nih.gov/17681169/
▪️Acute hemodynamic response:
pubmed.ncbi.nlm.nih.gov/19344721/
▪️Test-retest reliability:
pubmed.ncbi.nlm.nih.gov/34181770/
